Improved strength on 5-hydroxytryptophan and carbidopa in spinal cord atrophy

J Neurol Sci. 2017 Jul 15:378:59-62. doi: 10.1016/j.jns.2017.04.047. Epub 2017 Apr 27.

Abstract

There is ample evidence of an important role of descending serotonergic projections in modulating spinal motor neuron activation and firing, and experimental studies suggest that 5-HT receptor stimulation can improve motor function after spinal cord injury; however, relevant clinical data is sorely lacking. We describe two sisters with hemiplegic migraine, low CSF and platelet serotonin levels, and progressive spastic paraparesis associated with profound spinal cord atrophy whose lower extremity strength and ambulation responded to a precursor replacement strategy (5-hydroxytryptophan and carbidopa administration), an approach that may have broader applicability in myelopathies of diverse etiology where descending serotonergic projections are compromised.

Keywords: 5-Hydroxytryptophan; 5HIAA; Hemiplegic migraine; Neurodegeneration; Serotonin; Spinal cord atrophy.

Publication types

  • Case Reports

MeSH terms

  • 5-Hydroxytryptophan / therapeutic use*
  • Adult
  • Atrophy
  • Carbidopa / therapeutic use*
  • Central Nervous System Agents / therapeutic use*
  • Fatal Outcome
  • Female
  • Humans
  • Paraparesis / drug therapy
  • Paraparesis / physiopathology
  • Pregnancy
  • Pregnancy Complications / physiopathology
  • Spinal Cord Diseases / drug therapy*
  • Spinal Cord Diseases / physiopathology
  • Young Adult

Substances

  • Central Nervous System Agents
  • 5-Hydroxytryptophan
  • Carbidopa